Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan-Mar;10(1):197-205.
doi: 10.1111/j.1582-4934.2006.tb00300.x.

A new scoring system using multiple immunohistochemical markers for diagnosis of uterine smooth muscle tumors

Lea Rath-Wolfson  1 , Yevgenia Rosenblat, Marisa Halpern, M Herbert, I Hammel, Rivka Gal, M Leabu, Rumelia Koren
Affiliations

A new scoring system using multiple immunohistochemical markers for diagnosis of uterine smooth muscle tumors

Lea Rath-Wolfson et al. J Cell Mol Med. 2006 Jan-Mar.

Abstract

The diagnosis of uterine smooth muscle neoplasms by light microscopy is difficult. Multiple classification schemes have been proposed based on mitotic rate, nuclear atypia, and the presence or absence of necrosis. None of these classification systems has been entirely successful. This study was undertaken to evaluate the use of selected immunohistochemical and histochemical markers in differentiating these tumors, in addition to accepted morphologic criteria. Ten cases of each of the following: leiomyosarcomas (LMS), atypical leiomyomas (AL), cellular leiomyomas (CL) and usual leiomyomas (UL), were classically evaluated for histological diagnosis and were stained for Ki-67 (MIB-1), bcl- 2 and p53 using monoclonal antibodies and the avidin-biotin peroxidase method, and argyrophilic nucleolar organizer region (AgNORs). The number of stained cells was counted in the most positively stained region in a 4 mm2 square cover glass mounted on each slide. The mean value was calculated for each group of tumors. The data for Ki-67 (MIB- 1), bcl-2, p53 and AgNOR staining respectively, were significantly higher in LMS by comparison to UL, CL or AL. Because many singular cases had superimposed data being difficult to diagnose, a new scoring system for pathological evaluation was created. The results obtained by this scoring system suggest that immunohistochemical markers Ki-67 (MIB-1), bcl-2, p53 together with the AgNOR staining could be useful, by the scoring system, as an adjunct to the current accepted morphologic criteria in differentiating smooth muscle tumors of the uterus.

PubMed Disclaimer

References

    1. Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 1999;18:20–8. - PubMed
    1. Zhai YL, Nikaido T, Toki T, Shiozawa A, Orii A, Fujii S. Prognostic significance fo bcl-2 expression in leiomyosarcoma of the uterus. Br J Cancer. 1999;80:1658–64. - PMC - PubMed
    1. Peters WA, 3rd, Howard DR, Andersen WA, Figge DC. Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol. 1994;83:1015–20. - PubMed
    1. Hendrickson MR, Kempson RL. Pure mesenchymal neoplasms of the uterine corpus. In: Fox H, Wells M, editors. Obstetrical and Gynaecological Pathology. 4th. Churchill Livingstone; 1995. pp. 542–73. Edinburgh:
    1. Layfield LJ, Liu K, Dodge R, Barsky SH. Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med. 2000;124:221–7. - PubMed

Publication types